The aim of this systematic review and meta-analysis was to conduct a comprehensive
assessment of the evidence on the efficacy and safety of oral dydrogesterone versus …

The pharmacological and physiological profiles of progestogens used for luteal phase
support during assisted reproductive technology are likely to be important in guiding clinical …

Selective androgen receptor modulators (SARMs) are a novel class of androgen receptor
(AR) ligands that might change the future of androgen therapy dramatically. With improved …

This review deals with the effect of variations in phospholipid and sterol structure on the
nature and magnitude of lipid-sterol interactions in lipid bilayer model membranes. The first …

Dydrogesterone has a molecular structure closely related to that of natural progesterone, but
it has enhanced oral availability compared with progesterone. The hormonal profile and the …

Dydrogesterone is widely used for menstrual disorders, endometriosis, threatened and
habitual abortion and postmenopausal hormone replacement therapy. Although progestins …

Objective To compare the effectiveness of two different treatment regimens of
dydrogesterone in the management of endometriosis-related chronic pelvic pain. Design …

STUDY QUESTION Is there an association between dydrogesterone exposure during early
pregnancy and the reporting of birth defects? SUMMARY ANSWER This observational …

Progestins are a broad class of progestational agents widely differing in their chemical
structures and pharmacological properties. Despite emerging data suggest that progestins …

Objective Among postmenopausal women, oral, ultra-low-dose continuous combined
estradiol (E0. 5 mg) plus dydrogesterone (D2. 5 mg) reduces vasomotor symptoms (VMS) …